PLSCR Antibodies

Santa Cruz Biotechnology features a diverse variety of PLSCR monoclonal antibodies for investigating phospholipid scramblase proteins. PLSCR monoclonal antibodies are compatible with multiple research applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Phospholipid scramblase proteins maintain cellular membrane integrity and are essential for processes such as apoptosis, blood coagulation, and immune response. The translocation of phospholipids across the plasma membrane, facilitated by phospholipid scramblase proteins, plays a vital role in cell signaling and membrane dynamics. Research focused on phospholipid scramblase proteins continues to reveal their significance in various pathological conditions, including cancer and autoimmune diseases. Scientists worldwide are uncovering new functions and regulatory mechanisms of phospholipid scramblase proteins, expanding our understanding of cellular processes. Investigating phospholipid scramblase proteins can lead to breakthroughs in therapeutic strategies for multiple diseases. PLSCR monoclonal antibodies from Santa Cruz Biotechnology enable researchers to advance scientific knowledge and contribute to potential medical innovations.